Skip to main content

Azathioprine (Imuran)

A steroid-sparing immunosuppressant for autoimmune eye disease; carries an FDA Boxed Warning for malignancy. Many prescribers test TPMT and NUDT15 before starting to flag patients at high risk of severe myelosuppression.

Drug Class: Immunosuppressants

4 min read

Azathioprine (brand name Imuran) is an immunosuppressant medication that reduces immune system activity. It is often used as a steroid-sparing agent, allowing patients to reduce their steroid dose while maintaining disease control.

Key Takeaways

  • Steroid-sparing immunosuppressant that takes 3-6 months for full effect
  • FDA boxed warning for malignancy (lymphoma, skin cancer)
  • TPMT and NUDT15 testing is commonly done before starting to flag high-risk patients; the FDA label recommends considering it (and a known deficient genotype mandates dose change). It does not replace ongoing CBC monitoring.
  • Avoid combining with allopurinol or febuxostat without major dose reduction
  • Regular blood monitoring (CBC, LFTs) is required for the duration of treatment

How It Works

Azathioprine is converted to active metabolites that interfere with DNA synthesis, particularly in rapidly dividing cells like immune cells. This reduces immune activity and inflammation.

Common Uses

Dosing

  • Usually 1-3 mg/kg daily
  • Start low, increase gradually
  • Takes 3-6 months for full effect
  • TPMT testing recommended before starting

TPMT and NUDT15 Testing

TPMT and NUDT15 enzyme testing

Two genetic tests are commonly used to flag patients at high risk of severe bone marrow suppression on azathioprine:

  • TPMT (thiopurine S-methyltransferase) - low or absent activity is more common in patients of European ancestry; can cause severe bone marrow suppression at standard doses.
  • NUDT15 - variants are more common in patients of East Asian, South Asian, and Hispanic ancestry; predicts severe myelosuppression and is a CPIC Tier 1 actionable variant.

The FDA label recommends considering TPMT and NUDT15 evaluation - particularly in patients who develop severe myelosuppression or in those at higher risk by ancestry. CPIC and many specialists recommend testing before starting. Patients known to be deficient in either enzyme need substantial dose reduction or an alternative drug. Genetic testing does not replace ongoing CBC monitoring.

Side Effects

Common

  • Nausea, vomiting
  • Diarrhea
  • Fatigue
  • Increased infection risk

Serious (Monitor For)

  • Bone marrow suppression (low blood counts)
  • Liver problems
  • Increased cancer risk (long-term)
  • Severe infections

Monitoring

  • Complete blood count-regularly (weekly initially, then monthly)
  • Liver function tests
  • Watch for signs of infection
  • Report unusual bruising or bleeding

Frequently Asked Questions

Why does it take so long to work?

Azathioprine works by gradually reducing the immune cells that cause your condition. This process takes time-usually 3-6 months for significant effect.

Can I stop my steroids once I start this?

Not immediately. Azathioprine takes time to work. Your doctor will gradually taper steroids once azathioprine is effective.

Is this the same as chemotherapy?

Azathioprine is used in cancer treatment at higher doses, but for autoimmune disease, doses are lower. It still requires careful monitoring.

References

For current U.S. drug labeling, contraindications, boxed warnings, pregnancy/lactation language, and formulation-specific dosing, check the official label databases and your prescriber's instructions.

Was this article helpful?